News und Analysen
3 High-Yield Pharmaceutical Stocks
Pharmaceutical stocks are generally an outstanding place to look for sustainable sources of passive income. Even though most companies offer fairly modest yields due to the costly nature of....
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Gilead Sciences' (NASDAQ: GILD) recently approved Yescarta could be a billion-dollar blockbuster cancer-cell therapy, but the company could face stiff competition from Celgene (NASDAQ:....
Why TransEnterix Stock Tanked Today
Shares of TransEnterix (NYSEMKT: TRXC), an early commercial-stage robotic surgery company, ended today's trading session down another 16.4%. The company's shares have now given back a healthy....
Abbott Laboratories Q3 2017 Earnings Conference Call Transcript (ABT)
Abbott Laboratories (NYSE: ABT)Image source: The Motley Fool.Q3 2017 Earnings Conference CallOct. 18, 2017, 9:00 a.m. ET Continue readingSource: Fool.com
3 High-Yield Stocks for Conservative Investors
Conservative equates to cautious. We're talking investing here, of course, and not politics. Conservative investors are by nature cautious. There's nothing wrong with that. After all, Warren....
3 Things to Expect in Illumina's Q3 Earnings Results
A quick look at Illumina (NASDAQ: ILMN) stock's performance is all you need to know how the company's first two quarters in 2017 went. Illumina's share price has soared 60% so far this year after....
Here's Why Ignyta Stock Soared as Much as 27.5% Today
Shares of pre-revenue biopharma Ignyta (NASDAQ: RXDX) jumped over 27% Wednesday morning after it announced promising interim results from an ongoing phase 2/3 clinical trial investigating the....
Trump Cuts Cost-Sharing Subsidies, but It Won't Matter to Insurers
Donald Trump campaigned for president on a platform that includes repealing and replacing the Affordable Care Act, or Obamacare. However, Congress has failed to get a plan to his desk so far,....
What's Powering Johnson & Johnson's Impressive Quarterly Earnings?
Johnson & Johnson (NYSE: JNJ) surprised investors with better-than-hoped-for top-line and bottom-line performance in the third quarter, and that news sent shares soaring on Tuesday. The....
3 Things You Won't Learn by Focusing on Johnson & Johnson's Headline Figures in Its Q3 Report
Johnson & Johnson (NYSE: JNJ) often kicks things off for the healthcare sector with the release of its quarterly earnings, and once again, the largest healthcare company by market cap....
A Tiny Upstart Takes Aim at Robotic Surgery
Intuitive Surgical's (NASDAQ: ISRG) robots enjoy a near monopoly in hospitals, but that could change following last week's FDA approval of TransEnterix's (NYSEMKT: TRX) Senhance. Senhance is a....
UnitedHealth Looks Beyond Obamacare for Growth
Healthcare reform has been a priority among lawmakers in Congress, but they've thus far failed in their efforts to get rid of the Affordable Care Act. Health-insurance company UnitedHealth Group....
Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics
Ziopharm Oncology, Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) are both clinical-stage biotechs that could make you rich, but they'll need to carry at least one of their new....
The Country's Biggest Insurer Got Even Bigger in Q3
UnitedHealth Group (NYSE: UNH) is the largest health insurer in the country, and strong financial results in the third quarter show the company's still growing in spite of its decision last year....
Johnson & Johnson Q3 2017 Earnings Conference Call Transcript (JNJ)
Johnson & Johnson (NYSE: JNJ)Image source: The Motley Fool.Q3 2017 Earnings Conference CallOctober 17, 2017, 8:30 a.m. ETContinue readingSource: Fool.com
Johnson & Johnson Jumps on Pharma Strength
Johnson & Johnson (NYSE: JNJ) has been a behemoth in the U.S. healthcare space for decades. Yet as a mature company, J&J faces the inevitable challenge of finding ways to keep its growth....
Why TransEnterix Stock Is Soaring Today
Shares of the robotic-surgery company TransEnterix (NYSEMKT: TRXC) rose by as much as 69% today in early morning trading. This small-cap healthcare stock has now appreciated by over 200% since the....
3 Drug Stocks Hitting 52-Week Highs: Are They Buys?
October has often been a scary month for stocks. That isn't the case so far this year, though. And it's especially not true for three drug stocks.Biogen (NASDAQ: BIIB), Halozyme Therapeutics....
Should Intuitive Surgical Be Worried About Tiny TransEnterix?
TransEnterix (NYSEMKT: TRXC) shareholders have every reason to be excited. The U.S. Food and Drug Administration cleared the way for the company to market its Senhance Surgical Robotic System on....
Why TG Therapeutics Is Tumbling 15% Today
After TG Therapeutics, Inc.'s(NASDAQ: TGTX) discussion with the FDA regarding its most advanced clinical-stage drug raised concerns over a speedy approval, shares in the company are losing 15% of....
Why TransEnterix Is Skyrocketing Today
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55....
3 Questions You Need to Ask Ahead of Johnson & Johnson's Third-Quarter Report
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple holding in many investors' portfolios. Its superior 2.5% dividend yield and 55-year streak of raising its....
3 Growth Stocks at Value Stock Prices
It's not surprising that after an eight-year bull market, some are saying value investing is dead. With the cyclically adjusted P/E ratio of the S&P running at a red-hot 31, finding a value....
3 Healthcare Value Stocks
When value investors search through 10-Ks and valuation ratios for stocks selling on the cheap, healthcare isn't typically a sector full of stocks selling at a deep discount. When those stocks go....
Why 2017 Could Be This Stock's Best Year Yet
Nearly five years ago, Abbott Labs spun off its biopharmaceutical unit into a separate entity. That new company, AbbVie (NYSE: ABBV), enjoyed a tremendous first year, with its share price soaring....